ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Nov 24, 2021 12:27 JST
Source:
Mitsubishi Corporation
Smart-City Driverless-Vehicle Pilot Project to Enhance Mobility and Healthcare in Kamakura & Fujisawa Areas
TOKYO, Nov 24, 2021 - (JCN Newswire) - Mitsubishi Corporation (MC) has been in talks with Kamakura City's municipal government about developing its urban core and surrounding region into a smart city. Recently, our partnership joined forces with four other interests to commence a pilot project that will combine autonomous-driving technologies and healthcare services in Shonan Health Innovation Park (Shonan iPark). Along with Shonan iPark, our other partners on this project are Tokushukai Shonan Kamakura General Hospital (Kamakura General), Macnica, Inc. and Mitsubishi Electric Corporation.
One of the self-driving vehicles
The pilot-project site (Photo courtesy of Shonan iPark website)
Mitsubishi Corporation (MC) has been in talks with Kamakura City's municipal government about developing its urban core and surrounding region into a smart city. Recently, our partnership joined forces with four other interests to commence a pilot project that will combine autonomous-driving technologies and healthcare services in Shonan Health Innovation Park (Shonan iPark). Along with Shonan iPark, our other partners on this project are Tokushukai Shonan Kamakura General Hospital (Kamakura General), Macnica, Inc. and Mitsubishi Electric Corporation.
One of the keys to the scheme will be making local medical services more convenient and accessible. Recently, MC has been working with the five parties to monitor roughly 1,000 residents of Kamakura and Fujisawa cities and augment those cities' various medical services with self-driving vehicles.
The pilot project will likely involve the vehicles traveling to and from healthcare facilities to perform examinations, check patients' vital signs and take their medical histories using digital technologies. If the pilot project is successful and the program can be rolled out permanently, then it should improve accessibility to patients' homes and local healthcare facilities, enable those facilities to provide smoother treatments and reduce patient wait times.
Financial support for this pilot project is coming by way of Kanagawa Prefecture's publicly-funded program to assist businesses that are engaged in trials of robotics technologies, as well as funding from the cities of Kamakura and Fujisawa.
MC has been nominated by Kamakura City as a private partner in its "Super City Concept." We plan on making full use of our global business network, boosting the area's value through collaborations with its local enterprises, and examining ways to introduce a variety of municipal services that are both safe and dedicated to improving quality of life.
In this new age of digital transformation, MC has been leveraging advanced technologies to introduce a wealth of urban services both in Japan and around the world. We have also been combining those efforts with energy-transformation initiatives aimed at lowering or even eliminating carbon emissions. To help realize distributed, carbon-neutral societies, we remain committed to "smart" urban developments that represent the next generation of city-management business, and we are pleased to do our part to make services in Kamakura and its surrounding region more convenient and environmentally friendly.
Inquiry Recipient:
Mitsubishi Corporation
Telephone:+81-3-3210-2171
Facsimile:+81-3-5252-7705
Source: Mitsubishi Corporation
Sectors: Automotive, EVs, Transportation
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time
Mar 10, 2025 20:24 JST
CEPI funds Nagasaki University to develop innovative vaccines using Nanoball platform and NEC's AI
Mar 10, 2025 12:10 JST
Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels
Mar 07, 2025 16:24 JST
NEC improves the energy efficiency and floor space density of 5G Mobile Core systems
Mar 06, 2025 13:20 JST
Unmanned Aerial Vehicles Being Developed by MHI Used in Demonstration of Automated Transport and Unloading of Heavy Cargo in Disaster Areas
Mar 05, 2025 16:11 JST
Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan
Mar 05, 2025 09:09 JST
MHI-MS Completes Domestic Development of Vehicle Transport Robot
Mar 04, 2025 19:39 JST
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia
Mar 04, 2025 17:22 JST
Prideone Entertainment announces concept for post-war film to mark 80th anniversary of the end of World War II
Mar 04, 2025 16:00 JST
NTT and DOCOMO Successfully Demonstrates On-Demand Unified Control of Computing Services Through Network and Service Integration
Mar 03, 2025 20:25 JST
Space Compass and NTT DOCOMO Successfully Demonstrate Data Connectivity to 4G Devices via HAPS at 20 km Above Kenya
Mar 03, 2025 20:14 JST
TOPPAN and DOCOMO Agree to Innovate Next-Generation 6G Services Using FEEL TECH Communication Technology
Mar 03, 2025 18:32 JST
Rakuten Mobile Partners with Fujitsu to Accelerate 5G Network Expansion
Mar 03, 2025 18:23 JST
Fujitsu unveils 1FINITY 800G ZR/ZR+ coherent pluggable transceivers
Mar 03, 2025 17:58 JST
NEC develops and commercializes 5G-compatible virtualized base stations (vRAN)
Mar 03, 2025 17:42 JST
MHI-MS Delivers Merging Support Information System for Autonomous Truck Trial Project by MLIT
Mar 03, 2025 16:09 JST
"Fatigue Recovery While You Sleep!" Eisai to Launch Designated Quasi-Drug Drink "Chocola BB Nightwell"
Mar 03, 2025 15:41 JST
The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease
Mar 03, 2025 13:53 JST
Fujitsu's Oyama plant achieves top CSR score for sustainability in global telecom audit
Feb 28, 2025 16:57 JST
Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland China, Hong Kong, Macau, and Taiwan) with SciClone
Feb 28, 2025 12:31 JST
More Latest Release >>
Related Release
Mitsubishi and ENEOS to conduct Front End Engineering Design for Sustainable Aviation Fuel (SAF) Production at the Wakayama Refinery
2/24/2025 12:30:00 PM JST
Mitsubishi Logistics Corporation, Mitsubishi Corporation, and Yourstand Inc. Advancing Completely CO2-Free Electrification of Pharmaceutical Transportation
2/21/2025 3:01:00 PM JST
Launch of Joint Demonstration Experiment of Remote Provision of GPU Computing Power
2/17/2025 2:10:00 PM JST
Mitsubishi Corporation and JOGMEC Announce Investment in eFuels provider Infinium
1/17/2025 2:35:00 PM JST
Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism
11/15/2024 12:32:00 PM JST
Yoshimoto Kogyo and Mitsubishi Corporation have signed a business partnership agreement for co-creation of business using "laughter"
11/6/2024 11:51:00 AM JST
Joint Study by Idemitsu Kosan and Mitsubishi Corporation on Low-Carbon Ammonia
10/23/2024 6:15:00 PM JST
Mitsubishi Corporation (MC) to invest in Ayala joint venture with stake in Mynt
10/18/2024 11:05:00 PM JST
Launch of Japan's First EV Smart-charging Service Using Connected Technologies
10/10/2024 6:19:00 PM JST
Mitsubishi Corporation: JOGMEC Commissioned Feasibility Study for Overseas CCS Value Chain
9/30/2024 11:38:00 AM JST
More Press release >>